| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.76B | 43.19B | 40.81B | 45.46B | 40.45B | 32.83B |
| Gross Profit | 8.58B | 8.58B | 7.55B | 7.90B | 6.96B | 5.03B |
| EBITDA | 2.95B | 3.87B | 4.18B | 2.69B | 3.65B | 1.73B |
| Net Income | 1.70B | 2.19B | 2.54B | 647.00M | 1.95B | 447.00M |
Balance Sheet | ||||||
| Total Assets | 42.06B | 43.20B | 41.65B | 42.98B | 40.96B | 35.69B |
| Cash, Cash Equivalents and Short-Term Investments | 11.86B | 11.93B | 10.11B | 8.05B | 7.01B | 8.26B |
| Total Debt | 7.93B | 8.89B | 9.74B | 11.31B | 9.97B | 9.59B |
| Total Liabilities | 20.34B | 20.48B | 21.54B | 25.87B | 25.01B | 22.41B |
| Stockholders Equity | 21.71B | 22.71B | 20.11B | 17.11B | 15.95B | 13.29B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.11B | 3.82B | -128.00M | -2.06B | 1.59B |
| Operating Cash Flow | 0.00 | 4.12B | 4.52B | 629.00M | -909.00M | 2.05B |
| Investing Cash Flow | 0.00 | -1.47B | -737.00M | -1.04B | -1.06B | -590.00M |
| Financing Cash Flow | 0.00 | -1.91B | -2.48B | 773.00M | 23.00M | -558.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥16.61B | 10.33 | ― | 4.04% | 4.08% | -33.22% | |
72 Outperform | ¥25.73B | 16.96 | ― | 2.56% | 3.56% | -44.16% | |
69 Neutral | ¥18.73B | 17.47 | ― | 3.16% | 2.10% | 4.70% | |
69 Neutral | ¥16.50B | 15.47 | ― | 2.64% | 2.16% | -15.53% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
58 Neutral | ¥34.27B | ― | ― | 1.87% | 5.16% | -5946.54% | |
52 Neutral | €18.14B | 67.44 | -1.44% | 4.59% | -4.22% | -129.65% |